speb/financial-data huggingface dataset:
Financial scorecard for ZSTK (Financial Services — Asset Management, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 1.45
Market cap: 3524671 (USD: 3524671)
P/B ratio: 0.5674681871239503
Debt to equity: 0.0964
Current ratio: 1.39
Interest coverage ratio: -28.954545454545453
Return on net tangible assets (%): -1084.4970414201184
Buffett classification: The Gruesome
Analyst consensus upside (%): 77.99352750809062
Rule of 40 score: -114.32875956138803
Altman Z-score: -9.286552192748267 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 1044.4632951417552
Total shareholder yield (%): 1044.4632951417552 (High Return)
Momentum (%): 1m -59.26966292134832, 3m -78.2934131736527, 6m -78.35820895522387, 12m -94.12717699473473, composite -80.74427636508658 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): 8.991024483064303
Revenue deceleration: no
Accrual ratio: -0.37008623019264886
FCF conversion rate: 0.10493726132024003
Beneish M-score: -2.7160868328797365 (Likely Safe)
ROE (%): -67.65150963599812
Net margin (%): -503.9868023095958
Asset turnover: 0.08204087521474195
Equity multiplier (leverage): 1.6361685615564798
ROE archetype: Low Return
Treasury beta 1y: -0.028578086818815053 (R-squared: 0.007142225474042657)
Insider 90-day net shares: 4608575 (net value USD: 7604149.00)
Dividend increase streak (years): 0
ROIC (%): -7.499507936107398 (pretax: -9.49304802038911)
Incremental ROIC 3y (%): 10.996460828755662 (pretax: 13.919570669310966)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 20.875113947128533, ROIC 17.502278942570648, revenue growth 1y 17.046490428441203, 6m momentum 86.96444849589791
Sector percentiles: P/E , 6m momentum 70.2534919813761
Industry median P/E: 7.917582417582417; industry median ROIC: 1.6915626385800535
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.05299108094957009
Base cash flow: -87063503.64963503
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ZTF.L (Basic Materials — Specialty Chemicals, United Kingdom)
Report date: 2025-12-31 (annual)
Stock price: 0.06266666666666666
Market cap: 230908928 (USD: 312039091.8918919)
P/E ratio: 0.11951951951951953
P/B ratio: 0.01504807681639619
Debt to equity: 0.43829999999999997
Current ratio: 1.02
Interest coverage ratio: 10.967444120505345
Return on net tangible assets (%): 18.091851555065855
Buffett classification: The Good
Analyst consensus upside (%): 1139648.743718593
Rule of 40 score: 28.080230319289377
Piotroski F-score: 1 (Weak)
Magic formula: return on capital % 19.96020516448532, earnings yield % 11.183708462302551, rank 1030
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -8.30925944873306
Total shareholder yield (%): -8.30925944873306 (Minimal or Negative)
Momentum (%): 1m 10.759689922480622, 3m 19.21165381319621, 6m 21.714785651793512, 12m 54.0642303433001, composite 26.67472794196399 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 10, short score 1, recommendation: Strong Long (L/S Compounder)
Revenue deceleration: no
Accrual ratio: 0.008823450158085746
FCF conversion rate: 0.9242457705729051
Beneish M-score: -1.6912062240108754 (Possible Manipulation)
Equity multiplier (leverage): 1.6351293056034615
ROE archetype: Standard Business
P/E z-score: 4.961445016900331
FCF z-score: 4.961445016900331
Treasury beta 1y: 0.0019898275581578476 (R-squared: 0.0003105245368323871)
Insider 90-day net shares: 136 (net value USD: 794.00)
Dividend increase streak (years): 0
ROIC (%): 10.30037952527569 (pretax: 13.038455095285684)
Incremental ROIC 3y (%): 15.129771713421203 (pretax: 20.03998010509287)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 23.953488372093023, P/B 1.3953488372093024, ROIC 23.488372093023255, revenue growth 1y , 6m momentum 20.232558139534884
Sector percentiles: P/E 7.523598001110495, 6m momentum 10.022209883398112
Industry median P/E: 0.2375559102197765; industry median ROIC: 5.779832452013451
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.09343794854795756
Base cash flow: 24408108.108108103
DCF price per share: base 0.15656228422019106, conservative 0.09149106941031113, aggressive 0.26494195395969333
Financial scorecard for ZTS (Healthcare — Drug Manufacturers - Specialty & Generic, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 75.94
Market cap: 31588839424 (USD: 31588839424)
P/E ratio: 19.295081967213115
P/B ratio: 15.262341320321683
Debt to equity: 2.8624
Current ratio: 3.15
Interest coverage ratio: 13.258064516129032
Return on net tangible assets (%): -121.03174603174602
Buffett classification: The Great
Analyst consensus upside (%): -3.2965165675446126
Rule of 40 score: 6.522806077867258
Altman Z-score: 3.5785587326919153 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 9.760151982901924, earnings yield % 2.113010711007791, rank 340
Dividend yield (%): 0.7091112053639214
Buyback yield (%): 1.9183990645113231
Debt paydown yield (%): 0
Total shareholder yield (%): 2.6275102698752444 (Low Return)
Momentum (%): 1m -2.1769934303748526, 3m -35.02181911525627, 6m -38.5150999919035, 12m -49.705278495264594, composite -40.707639393315354 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 5, short score 4, recommendation: Neutral
Revenue growth 1y (%): 2.91173794358508
Net income growth 1y (%): -0.16611295681062677
Revenue deceleration: no
Accrual ratio: 0.02024754253616799
FCF conversion rate: 0.4841930116472546
Beneish M-score: -2.40272071990419 (Likely Safe)
ROE (%): 18.312004875076173
Net margin (%): 26.56940760389036
Asset turnover: 0.14774174586068384
Equity multiplier (leverage): 4.664990859232176
ROE archetype: Leverage-Driven Returns
P/E z-score: 4.459051369250961
FCF z-score: 4.459051369250968
Treasury beta 1y: -0.0020084431776108665 (R-squared: 0.0005828808400702325)
Insider 90-day net shares: 11650 (net value USD: 886367.00)
Dividend increase streak (years): 0
ROIC (%): 27.892991171514907 (pretax: 35.06189687104006)
Incremental ROIC 3y (%): 39.78817701398082 (pretax: 49.8138495904691)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 44.868035190615835, P/B 77.71260997067448, ROIC 5.865102639296188, revenue growth 1y 38.70967741935484, 6m momentum 78.00586510263929
Sector percentiles: P/E 22.922636103151863, 6m momentum 64.50573065902579
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07778603605548262
Base cash flow: 2539000000
DCF price per share: base 131.49574023552128, conservative 96.43727869812686, aggressive 180.05602565008593
Financial scorecard for ZUARIIND.NS (Industrials — Conglomerates, India)
Report date: 2026-03-31 (annual)
Stock price: 2.652766308835673
Market cap: 7653764096 (USD: 81112379.14370497)
P/E ratio: 0.06206494163567688
P/B ratio: 0.1754999552015677
Debt to equity: 0.721
Current ratio: 0.66
Interest coverage ratio: 0.16708070848131826
Return on net tangible assets (%): 3.224839781287831
Buffett classification: The Good
Rule of 40 score: 8.908092301061025
Altman Z-score: 0.06472101840876743 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -4.540530330820638, 3m -6.430854419052812, 6m -7.383304771403525, 12m -14.827570017316184, composite -8.196833996777835 (Moderate Downtrend)
Lynch category: Asset Play (confidence: High)
Screener: long score 1, short score 7, recommendation: Neutral
Revenue growth 1y (%): -2.3876091759341467
Revenue CAGR 3y (%): -1.6012401466438564
Net income CAGR 3y (%): -32.878082269303654
FCF CAGR 3y (%): -25.82653503920822
Revenue deceleration: yes
Revenue growth consistency score: 13.382629723607147
Beneish M-score: 4.579813661492943 (Strong Manipulation Signal)
ROE (%): -0.8605222980813654
Net margin (%): -10.935689858925153
Asset turnover: 0.039583741187146915
Equity multiplier (leverage): 1.987920924447002
ROE archetype: Low Return
P/E z-score: 3.554246775015488
FCF z-score: 3.5542467750154882
Treasury beta 1y: 0.0005311435020688847 (R-squared: 2.154265627385186e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Dividend increase streak (years): 0
ROIC (%): 0.6176498552975673 (pretax: 0.7137842300409956)
Incremental ROIC 3y (%): -5.668389447565516 (pretax: -4.441789762072921)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 11.913357400722022, P/B 6.4981949458483745, ROIC 63.1768953068592, revenue growth 1y 30.324909747292416, 6m momentum 57.03971119133574
Sector percentiles: P/E 6.579621095750128, 6m momentum 52.73937532002048
Industry median P/E: 0.1475398300795126; industry median ROIC: 4.422331016216076
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.05869562952857382
Base cash flow: 11913247.138618058
DCF price per share: base 0.037434651129707223, conservative 0.020243583075344, aggressive 0.06103283732175648
Financial scorecard for MOG.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-02-28 (quarterly)
Stock price: 0.39007092198581567
Market cap: 287793312 (USD: 210068110.94890508)
P/B ratio: 4.762490023319303
Debt to equity: 0
Current ratio: 22.05
Return on net tangible assets (%): -14.418353735826633
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 67.75561330477198 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 13.040961065277198, 3m 84.27488383467848, 6m -0.31520882584712595, 12m 141.13475177304971, composite 65.75864540413885 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.012313894409845512
FCF conversion rate: 1.0639524240576406
Beneish M-score: -2.5008126903350822 (Likely Safe)
ROE (%): -20.207678438597632
Asset turnover: 0
Equity multiplier (leverage): 1.0494892823608764
ROE archetype: Low Return
Treasury beta 1y: -0.02955274732066805 (R-squared: 0.004508924799717858)
Insider 90-day net shares: -600000 (net value USD: -218200.00)
ROIC (%): -9985.242146398734 (pretax: -12639.54702075789)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 43.38051623646961, ROIC 59.78351373855121, revenue growth 1y , 6m momentum 18.984179850124896
Sector percentiles: P/E , 6m momentum 24.319822320932815
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.15
Base cash flow: -10269931.42857143
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for MRVI (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 6.76
Market cap: 2493590528 (USD: 2493590528)
P/B ratio: 1.1310259321616005
Debt to equity: 0.8536
Current ratio: 5.91
Interest coverage ratio: 0.12523917202991824
Buffett classification: The Gruesome
Analyst consensus upside (%): 108.48056537102475
Rule of 40 score: 28.207794193906203
Altman Z-score: 4.8076048566418494 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 0.20222219725651883, earnings yield % 0.05522439463264045, rank 2855
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 3.762766939737108
Total shareholder yield (%): 3.762766939737108 (Low Return)
Momentum (%): 1m 17.36111111111111, 3m 90.4225352112676, 6m 82.21024258760107, 12m 149.44649446494464, composite 95.0596344200411 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 5, short score 3, recommendation: Neutral
Revenue growth 1y (%): 40.52721451440768
Revenue deceleration: no
Accrual ratio: -0.010730600069821013
FCF conversion rate: -1.1326011251004553
Beneish M-score: -2.375448387700209 (Likely Safe)
ROE (%): -1.0064788876696227
Net margin (%): -5.67006394580555
Asset turnover: 0.08874142906629896
Equity multiplier (leverage): 2.000277705131074
ROE archetype: Low Return
Treasury beta 1y: 0.0002869143920691787 (R-squared: 3.1092140989777233e-06)
Insider 90-day net shares: -50000 (net value USD: -254000.00)
ROIC (%): -19.506828630105144 (pretax: -24.6921881393736)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 12.815884476534295, ROIC 14.891696750902527, revenue growth 1y 9.927797833935017, 6m momentum 4.512635379061372
Sector percentiles: P/E , 6m momentum 3.080229226361032
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07220170653912342
Base cash flow: -82716000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NBIS (Communication Services — Internet Content & Information, Netherlands)
Report date: 2026-03-31 (quarterly)
Stock price: 187.77
Market cap: 47674466304 (USD: 47674466304)
P/E ratio: 47.163636363636364
P/B ratio: 2.7473925601766394
Debt to equity: 1.3243
Current ratio: 8.33
Interest coverage ratio: -2.009419152276295
Return on net tangible assets (%): -22.902707239696696
Buffett classification: The Gruesome
Analyst consensus upside (%): 148.77602158828066
Rule of 40 score: 8.495510731761023
Altman Z-score: 2.429508663354493 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -10.623016730058794
Total shareholder yield (%): -10.623016730058794 (Minimal or Negative)
Momentum (%): 1m -27.686205037356547, 3m 27.595814079913026, 6m 98.69841269841271, 12m 259.9884969325154, composite 174.70288131874665 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 5, short score 11, recommendation: Short
Revenue growth 1y (%): 728.9411286498206
Revenue deceleration: no
Accrual ratio: 0.04774115324894406
FCF conversion rate: -0.34594333547971673
Beneish M-score: -2.19936414394245 (Likely Safe)
ROE (%): 10.401880541487994
Net margin (%): 155.68922305764409
Asset turnover: 0.022782825195943886
Equity multiplier (leverage): 2.9325520726882677
ROE archetype: Standard Business
P/E z-score: 1.4127846182796178
Treasury beta 1y: 0.02481327959547504 (R-squared: 0.009854774544724446)
Insider 90-day net shares: -675363 (net value USD: -141792985.00)
ROIC (%): -7.37639076539163 (pretax: -10.387162506367806)
Incremental ROIC 3y (%): -20.825911813259083 (pretax: -30.36690100378758)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 51.652892561983464, P/B 44.214876033057855, ROIC 55.371900826446286, revenue growth 1y 0, 6m momentum 1.2396694214876034
Sector percentiles: P/E 48.65744507729862, 6m momentum 1.4646053702196908
Industry median P/E: 1.5943877551020407; industry median ROIC: 5.940137180901089
Sector median P/E: 1.436628982900151; sector median ROIC: 4.830798676039866
WACC: 0.092621994104059
Base cash flow: -4135294117.6470585
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NBIX (Healthcare — Drug Manufacturers - Specialty & Generic, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 175.77
Market cap: 17673670656 (USD: 17673670656)
P/E ratio: 20.267692307692307
P/B ratio: 3.8875549569818633
Debt to equity: 0.136
Current ratio: 2.93
Return on net tangible assets (%): 5.7551212067852315
Buffett classification: The Great
Analyst consensus upside (%): 53.46136329133139
Rule of 40 score: 10.877907754354558
Altman Z-score: 7.926911822757884 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 8.681852128454072, earnings yield % 1.1057625958278121, rank 829
Dividend yield (%): 0
Buyback yield (%): 0.3055392456442977
Debt paydown yield (%): 0.05148902102524276
Total shareholder yield (%): 0.35702826666954046 (Low Return)
Momentum (%): 1m 5.847284114175604, 3m 37.66447368421053, 6m 29.071816713173742, 12m 33.52324521422062, composite 30.961119385981124 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 7, short score 0, recommendation: Neutral
Revenue growth 1y (%): 42.24589591337757
Net income growth 1y (%): 2405.0632911392404
Revenue deceleration: no
Accrual ratio: 0.01283328265724441
FCF conversion rate: 0.6907529055078322
Beneish M-score: -2.2841310676006543 (Likely Safe)
ROE (%): 5.942496809548833
Net margin (%): 24.297114794352364
Asset turnover: 0.17079589418832633
Equity multiplier (leverage): 1.431979581112529
ROE archetype: Standard Business
P/E z-score: 4.74303126030035
FCF z-score: 4.743031260300348
Treasury beta 1y: -0.0005414245040561844 (R-squared: 5.479245709215457e-05)
Insider 90-day net shares: -394172 (net value USD: -62221560.00)
ROIC (%): 19.73732667658061 (pretax: 29.090493601462526)
Incremental ROIC 3y (%): 20.885129517712794 (pretax: 32.11503397977789)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 46.04105571847507, P/B 63.63636363636363, ROIC 11.143695014662756, revenue growth 1y 6.451612903225806, 6m momentum 14.369501466275661
Sector percentiles: P/E 23.674785100286535, 6m momentum 10.85243553008596
Industry median P/E: 0.8814835040505258; industry median ROIC: 5.747543732928968
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.06770030303432267
Base cash flow: 474700000
DCF price per share: base 321.37325209953286, conservative 174.10366336083788, aggressive 605.6250496986885
Financial scorecard for NBVA.V (Technology — Software - Infrastructure, Canada)
Report date: 2026-01-31 (quarterly)
Stock price: 0.09929078014184399
Market cap: 10175198 (USD: 7537183.703703703)
P/B ratio: 3.746663476245003
Debt to equity: 0.0052
Current ratio: 12.64
Interest coverage ratio: -224.35081967213114
Return on net tangible assets (%): -4.106887786973327
Buffett classification: The Gruesome
Rule of 40 score: -156.19009845686932
Altman Z-score: 16.55038775786968 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.006924400179450322
Total shareholder yield (%): -0.006924400179450322 (Minimal or Negative)
Momentum (%): 1m -6.0047281323876875, 3m -19.983312473925725, 6m -19.399249061326657, 12m 50.03940110323095, composite 6.747283870095852 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 13, recommendation: Short
Revenue growth 1y (%): 94.21101025344552
Revenue deceleration: no
Accrual ratio: 0.033870638788764874
FCF conversion rate: 1.8995015827535622
Beneish M-score: -2.139121700290587 (Likely Safe)
ROE (%): -4.171859098070646
Net margin (%): -83.51949903633276
Asset turnover: 0.04508515580127322
Equity multiplier (leverage): 1.1079194240009893
ROE archetype: Low Return
Treasury beta 1y: 0.0007740660611392595 (R-squared: 4.5910333306670556e-06)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -350.46801849089235 (pretax: -443.6304031530283)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 45.70135746606335, ROIC 71.04072398190046, revenue growth 1y 4.97737556561086, 6m momentum 45.47511312217195
Sector percentiles: P/E , 6m momentum 54.154154154154156
Industry median P/E: 5.36821412369575; industry median ROIC: 3.7232145830700096
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.10501991459948339
Base cash flow: -467381.15942028986
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NBY.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.056737588652482275
Market cap: 14067799 (USD: 10120718.705035971)
P/B ratio: 2.3549147647271447
Debt to equity: 0
Current ratio: 6.39
Return on net tangible assets (%): -17.393773758399618
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -8.31085321967851 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -10.480693459416853, 3m -13.63278171788808, 6m -51.06382978723405, 12m -22.83687943262411, composite -26.16647613551019 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.030268881930886622
FCF conversion rate: 0.7965661516955203
Beneish M-score: -2.6670471813824905 (Likely Safe)
ROE (%): -17.524683249259503
Asset turnover: 0
Equity multiplier (leverage): 1.1778148138587317
ROE archetype: Low Return
Treasury beta 1y: 0.0006768843149039448 (R-squared: 4.225981704851062e-06)
Insider 90-day net shares: 60000 (net value USD: 4085.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 31.05745212323064, ROIC , revenue growth 1y , 6m momentum 65.02914238134888
Sector percentiles: P/E , 6m momentum 72.68184342032204
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05845
Base cash flow: -2120915.328467153
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NC6.AX (Consumer Cyclical — Textile Manufacturing, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.05555555555555556
Market cap: 31080530 (USD: 20314071.895424835)
P/B ratio: 72.21496245058792
Debt to equity: 0.03301119292855143
Current ratio: 0.71
Interest coverage ratio: -46.752616827775554
Return on net tangible assets (%): -350.80257611418455
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 61.11111111111113, 3m -2.77777777777778, 6m 15.87301587301587, 12m 4.861111111111119, composite -7.272851669403397 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.6593831623184273
FCF conversion rate: 0.7701261591697443
Beneish M-score: -2.27758699501555 (Likely Safe)
ROE (%): -1695.6826573792682
Equity multiplier (leverage): 5.911480722536092
ROE archetype: Low Return
Treasury beta 1y: 0.0029585945630289157 (R-squared: 0.00013758605410474904)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 83.1081081081081, ROIC , revenue growth 1y , 6m momentum 22.972972972972975
Sector percentiles: P/E , 6m momentum 15.403337969401948
Industry median P/E: 0.18251138762789332; industry median ROIC: 4.332358383927475
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.08485753741468995
Base cash flow: -908901.9607843137
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NTHI (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 3.43
Market cap: 88946296 (USD: 88946296)
Debt to equity: -0.026154386253969323
Current ratio: 0.13
Interest coverage ratio: -7.132472848210505
Buffett classification: The Gruesome
Analyst consensus upside (%): 128.2453637660485
Rule of 40 score: 0
Altman Z-score: -59.94674928575604 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 6.709471072297378
Total shareholder yield (%): 6.709471072297378 (Moderate Return)
Momentum (%): 1m -27.17622080679405, 3m -28.24267782426778, 6m -61.675977653631286, 12m -27.02127659574468, composite -29.901963173484088 (Flat)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 9, recommendation: Short
Revenue growth 1y (%): -100
Revenue deceleration: no
Accrual ratio: -0.5941566139268533
FCF conversion rate: 0.7927241389162637
Beneish M-score: -2.5211198968563076 (Likely Safe)
Asset turnover: 0
ROE archetype: Standard Business
Treasury beta 1y: -0.01848977675478611 (R-squared: 0.006460157950312324)
Insider 90-day net shares: 30500 (net value USD: 138212.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y 29.693140794223826, 6m momentum 70.7581227436823
Sector percentiles: P/E , 6m momentum 74.10458452722062
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.10794801931997021
Base cash flow: -62609749
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NTLX.V (Healthcare — Drug Manufacturers - General, United States)
Report date: 2025-12-31 (annual)
Stock price: 0.12056737588652484
Market cap: 14433000 (USD: 14433000)
P/B ratio: 16.257772370911056
Debt to equity: 1.4413999999999998
Current ratio: 1.35
Interest coverage ratio: -33.176
Buffett classification: The Gruesome
Rule of 40 score: -238.78504672897196
Altman Z-score: -11.787473403311996 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 7.003546099290797, 3m 3.2358156028369014, 6m -2.1276595744680833, 12m 9.314420803782543, composite 1.0892601471714587 (Flat)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -1.3036840366808837
FCF conversion rate: 0.40261945185544507
Beneish M-score: -7.7709097753090095 (Likely Safe)
ROE (%): -617.5201125915913
Net margin (%): -466.33472663551396
Asset turnover: 0.45160605357233785
Equity multiplier (leverage): 2.9322000373807846
ROE archetype: Low Return
Treasury beta 1y: 0.002270655921154429 (R-squared: 8.036790827876093e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 70.83333333333334, ROIC , revenue growth 1y , 6m momentum 55.55555555555556
Sector percentiles: P/E , 6m momentum 31.805157593123205
Industry median P/E: 16.627450980392158; industry median ROIC: 15.669270196462376
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -3929000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for NWPX (Basic Materials — Steel, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 129.31
Market cap: 1246161536 (USD: 1246161536)
P/E ratio: 18.27699530516432
P/B ratio: 1.8585221804779455
Debt to equity: 0.2738
Current ratio: 2.68
Interest coverage ratio: 36.37068965517241
Return on net tangible assets (%): 3.6452768137854155
Buffett classification: The Good
Analyst consensus upside (%): 40.418700231184175
Rule of 40 score: 27.75589189711334
Altman Z-score: 4.529225520174685 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 2.886036118205035, earnings yield % 0.9428723386402086, rank 1804
Dividend yield (%): 0
Buyback yield (%): 0.19387534683144
Debt paydown yield (%): 0.02977142122287427
Total shareholder yield (%): 0.22364676805431427 (Low Return)
Momentum (%): 1m -9.907336445342436, 3m 52.5241802311866, 6m 91.9685273159145, 12m 213.32687181972375, composite 130.75853356327323 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 8, short score 2, recommendation: Long
Revenue growth 1y (%): 19.06644275072127
Net income growth 1y (%): 165.74167507568114
Revenue deceleration: no
Accrual ratio: -0.025148092307438807
FCF conversion rate: 2.4488323523827606
Beneish M-score: -2.4014144910288913 (Likely Safe)
ROE (%): 2.6384107419935354
Net margin (%): 7.619309387070175
Asset turnover: 0.22780922250508745
Equity multiplier (leverage): 1.5200416775723815
ROE archetype: Low Return
P/E z-score: 4.367922798140405
FCF z-score: 3.6668797981238015
Treasury beta 1y: 0.01739046862197903 (R-squared: 0.03259254179911755)
Insider 90-day net shares: -21302 (net value USD: -1535783.00)
ROIC (%): 7.824775640758001 (pretax: 10.270252809329032)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 65.23809523809524, P/B 60.476190476190474, ROIC 29.04761904761905, revenue growth 1y 8.095238095238095, 6m momentum 0.9523809523809524
Sector percentiles: P/E 29.872293170460857, 6m momentum 1.8878400888395337
Industry median P/E: 0.24968437316139946; industry median ROIC: 5.061127786090195
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.09314929224613354
Base cash flow: 34672000
DCF price per share: base 53.550163730724655, conservative 41.13044932647256, aggressive 69.72647725159703
Financial scorecard for NXL (Healthcare — Medical Devices, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 0.48
Market cap: 10591839 (USD: 10591839)
P/B ratio: 2.6691745294703995
Debt to equity: 0
Current ratio: 4.07
Return on net tangible assets (%): -84.49959021891532
Buffett classification: The Gruesome
Analyst consensus upside (%): 471.42857142857144
Rule of 40 score: -15281.082094430167
Altman Z-score: -29.206279796836032 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 41.17647058823528, 3m 11.627906976744184, 6m -21.311475409836067, 12m -59.66386554621849, composite -27.037379953887765 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): -63.5499207606973
Revenue deceleration: no
Accrual ratio: -0.07312791238172801
FCF conversion rate: 0.8547450278681652
Beneish M-score: 0.07822437727212639 (Strong Manipulation Signal)
ROE (%): -63.21243304636316
Net margin (%): -14025.665551839464
Asset turnover: 0.003589456457852338
Equity multiplier (leverage): 1.2555971996855713
ROE archetype: Low Return
Treasury beta 1y: 0.01766528533072999 (R-squared: 0.002736689641044063)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -26757.06785339469 (pretax: -33869.70614353758)
Incremental ROIC 3y (%): -660.1621255871206 (pretax: -835.6482602368617)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 37.0919881305638, ROIC 72.40356083086054, revenue growth 1y 58.45697329376854, 6m momentum 46.29080118694362
Sector percentiles: P/E , 6m momentum 51.28939828080229
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -8297503
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OLPX (Consumer Cyclical — Specialty Retail, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 2.07
Market cap: 1391282176 (USD: 1391282176)
P/B ratio: 1.5540082480130661
Debt to equity: 0.40149999999999997
Current ratio: 6.27
Interest coverage ratio: -0.7166292765002804
Buffett classification: The Gruesome
Analyst consensus upside (%): 0
Rule of 40 score: -1.7525339982380594
Altman Z-score: 2.3080902544366535 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 5.165776762808791, earnings yield % 1.3453104896183485, rank 4742
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.013943972211141156
Total shareholder yield (%): -0.013943972211141156 (Minimal or Negative)
Momentum (%): 1m 1.470588235294108, 3m 2.4752475247524663, 6m 26.219512195121947, 12m 37.08609271523178, composite 21.26469915607293 (Strong Uptrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 6, short score 4, recommendation: Neutral
Revenue growth 1y (%): 2.465507640908249
Net income growth 1y (%): -1236.989247311828
Revenue deceleration: no
Accrual ratio: -0.008451215665245846
FCF conversion rate: -1.3639114809911104
Beneish M-score: -2.256782433414571 (Likely Safe)
ROE (%): -0.6016925233985214
Net margin (%): -5.320572814459238
Asset turnover: 0.06719385897262078
Equity multiplier (leverage): 1.6830097827670345
ROE archetype: Low Return
FCF z-score: 5.121433385687478
Treasury beta 1y: -0.0005474129153730582 (R-squared: 9.190669622323096e-06)
Insider 90-day net shares: -695074 (net value USD: -856577.00)
ROIC (%): 1.6500932691749484 (pretax: 2.088725657183479)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 40.375586854460096, ROIC 60.56338028169014, revenue growth 1y 30.046948356807512, 6m momentum 10.7981220657277
Sector percentiles: P/E , 6m momentum 10.048678720445062
Industry median P/E: 2.3211958916121533; industry median ROIC: 6.169113478954271
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.1325252915956978
Base cash flow: 44329000
DCF price per share: base 0.5587607172352141, conservative 0.5109843573195527, aggressive 0.6126664115723149
Financial scorecard for OMDA (Healthcare — Health Information Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 20.53
Market cap: 1220477952 (USD: 1220477952)
P/B ratio: 3.1918422888885094
Debt to equity: 0
Current ratio: 3.92
Interest coverage ratio: -265.6111111111111
Return on net tangible assets (%): -0.7035079464420314
Buffett classification: The Gruesome
Analyst consensus upside (%): 95.54494828957834
Rule of 40 score: -19.646974177201624
Altman Z-score: 9.538010974786921 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 10.376344086021504, 3m 43.2658757850663, 6m 24.273607748184027, 12m 8.797032326444091, composite 22.036213641979042 (Moderate Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 15, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 42.000982479122314
Revenue deceleration: no
Accrual ratio: 0.034268107411329095
FCF conversion rate: 4.508754208754209
Beneish M-score: -2.143102265533658 (Likely Safe)
ROE (%): -1.2807299729623671
Net margin (%): -3.805350553505535
Asset turnover: 0.2566507290317065
Equity multiplier (leverage): 1.3113553745380533
ROE archetype: Low Return
FCF z-score: 1.5608454575078252
Treasury beta 1y: 0.01044654934803031 (R-squared: 0.0064119735155783964)
Insider 90-day net shares: -335735 (net value USD: -6752844.00)
ROIC (%): -123.7294610151753 (pretax: -156.6195709052852)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 38.421052631578945, ROIC 56.84210526315789, revenue growth 1y 6.842105263157896, 6m momentum 11.052631578947368
Sector percentiles: P/E , 6m momentum 12.679083094555873
Industry median P/E: 8.33027298322928; industry median ROIC: 0.6291287571896624
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1019
Base cash flow: -8609000
DCF price per share: base 0, conservative 0.9604952198762137, aggressive 0
Financial scorecard for OMER (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 9.79
Market cap: 708554688 (USD: 708554688)
P/E ratio: 9.263157894736842
Debt to equity: -2.350175261313039
Current ratio: 3.03
Interest coverage ratio: -2.9557176789955886
Return on net tangible assets (%): -88.89222218713488
Buffett classification: The Gruesome
Analyst consensus upside (%): 212.49999999999994
Rule of 40 score: -165.72323865359346
Altman Z-score: -2.638600445765634 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0.5859815862230242
Debt paydown yield (%): 12.743829309051161
Total shareholder yield (%): 13.329810895274186 (High Return)
Momentum (%): 1m -7.466918714555774, 3m -27.64227642276423, 6m -17.937971500419117, 12m 172.70194986072423, composite 49.70909098939385 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 1, short score 10, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: 0.23068134454605635
FCF conversion rate: -0.25875847306457367
Beneish M-score: -2.463396529983296 (Likely Safe)
Net margin (%): 566.6632972809057
Asset turnover: 0.03234036988909865
ROE archetype: Standard Business
Treasury beta 1y: 0.0037881988031750005 (R-squared: 7.684047786877914e-05)
Insider 90-day net shares: -7500 (net value USD: -87039.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E 7.851985559566788, P/B , ROIC , revenue growth 1y , 6m momentum 41.69675090252707
Sector percentiles: P/E 19.555873925501434, 6m momentum 48.06590257879656
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -242321000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OMM.V (Basic Materials — Gold, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.03546099290780142
Market cap: 14725930 (USD: 10594194.244604317)
P/B ratio: 2.959446456342749
Debt to equity: 2.1772
Current ratio: 0.06
Interest coverage ratio: -0.9310450279447432
Return on net tangible assets (%): -9.811040808273441
Buffett classification: The Gruesome
Analyst consensus upside (%): 872.9999999999999
Rule of 40 score: 0
Altman Z-score: -1.8829376747396764 (Distress Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.34063891499677157
Total shareholder yield (%): -0.34063891499677157 (Minimal or Negative)
Momentum (%): 1m -16.075650118203303, 3m -30.597771023302933, 6m -62.35679214402619, 12m -3.546099290780138, composite -26.00832856751347 (Moderate Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 13, recommendation: Strong Short (Melting Ice Cube)
Revenue deceleration: no
Accrual ratio: -0.018876874574977283
FCF conversion rate: 0.23296136275299537
Beneish M-score: -2.515973121064096 (Likely Safe)
ROE (%): -9.588070529732981
Asset turnover: 0
Equity multiplier (leverage): 3.895994818285962
ROE archetype: Low Return
Treasury beta 1y: -0.0012562306312414464 (R-squared: 1.2640505507630248e-05)
Insider 90-day net shares: 2486667 (net value USD: 72113.00)
ROIC (%): -6.78301122543102 (pretax: -8.586090158773443)
Incremental ROIC 3y (%): -9.643637278361815 (pretax: -12.2071357953947)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 31.728045325779036, ROIC 28.04532577903683, revenue growth 1y , 6m momentum 76.62889518413598
Sector percentiles: P/E , 6m momentum 79.17823431426984
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.06257007848054931
Base cash flow: -1706004.3795620436
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ORV.TO (Basic Materials — Other Precious Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 1.3475177304964538
Market cap: 259584016 (USD: 186751090.64748204)
P/E ratio: 2.9128880549739553
P/B ratio: 4.038027990903137
Debt to equity: 1.669
Current ratio: 0.66
Interest coverage ratio: 32.52827763496144
Return on net tangible assets (%): 12.52145903757323
Buffett classification: The Good
Rule of 40 score: 108.86558195004
Altman Z-score: 0.9056288991301945 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Magic formula: return on capital % 34.54833381114252, earnings yield % 5.951753473091966, rank 14
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.03629051627046872
Total shareholder yield (%): 0.03629051627046872 (Low Return)
Momentum (%): 1m 29.288863331416525, 3m 3.1340385910693844, 6m -20.189936992055532, 12m 239.37483582873656, composite 48.479193664633904 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 8, short score 2, recommendation: Long
Revenue growth 1y (%): 123.07605198276134
Net income growth 1y (%): 3937.176511295974
Revenue deceleration: no
Accrual ratio: 0.02068635971366219
FCF conversion rate: 0.7681033602287816
Beneish M-score: -2.2653373254677764 (Likely Safe)
ROE (%): 40.72038977056422
Net margin (%): 33.76497973963273
Asset turnover: 0.2641941051737147
Equity multiplier (leverage): 4.564805837603035
ROE archetype: Leverage-Driven Returns
Treasury beta 1y: -0.002450005650356552 (R-squared: 0.00013629304187730583)
Insider 90-day net shares: 29500 (net value USD: 7814.00)
ROIC (%): 13.61211260649463 (pretax: 17.23052228670206)
Incremental ROIC 3y (%): 81.3543330003119 (pretax: 102.98016835482517)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 4.584527220630372, P/B 34.95702005730659, ROIC 5.444126074498568, revenue growth 1y 2.5787965616045847, 6m momentum 28.36676217765043
Sector percentiles: P/E 20.46085508051083, 6m momentum 44.3364797334814
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05989609113901426
Base cash flow: -25105755.395683456
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PAL (Industrials — Integrated Freight & Logistics, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 6.84
Market cap: 189947312 (USD: 189947312)
P/B ratio: 0.6158319059295905
Debt to equity: 0.2667
Current ratio: 1.06
Interest coverage ratio: -4.971161492919577
Buffett classification: The Gruesome
Analyst consensus upside (%): 52.359882005899706
Rule of 40 score: -11.25523541846882
Altman Z-score: 0.7167050163690536 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0.2726461325233178
Debt paydown yield (%): 3.019117217094391
Total shareholder yield (%): 3.2917633496177086 (Low Return)
Momentum (%): 1m -4.469273743016763, 3m -2.285714285714288, 6m -31.872509960159356, 12m -15.555555555555554, composite -15.254387505826193 (Moderate Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 7, recommendation: Neutral
Revenue growth 1y (%): -1.5927059907272056
Revenue deceleration: no
Accrual ratio: -0.01628288003421281
FCF conversion rate: -0.18470976029494765
Beneish M-score: -1.8636741639224972 (Likely Safe)
ROE (%): -2.10333419966776
Net margin (%): -6.927232286411429
Asset turnover: 0.19840814921330696
Equity multiplier (leverage): 1.5303438643979572
ROE archetype: Low Return
FCF z-score: 3.419981420629314
Treasury beta 1y: 0.0058706672609448625 (R-squared: 0.001109123315595861)
Insider 90-day net shares: -47134 (net value USD: -224815.00)
ROIC (%): -1.6042694487500242 (pretax: -2.030720821202562)
Incremental ROIC 3y (%): -4.532756663854725 (pretax: -5.840916193022564)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 16.233766233766232, ROIC 77.27272727272727, revenue growth 1y 37.01298701298701, 6m momentum 77.27272727272727
Sector percentiles: P/E , 6m momentum 76.93292370711725
Industry median P/E: 1.6524312026398307; industry median ROIC: 5.860649403527186
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.1027085704155917
Base cash flow: 529027
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PCRX.V (Healthcare — Pharmaceutical Retailers, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.3475177304964539
Market cap: 96349128 (USD: 69315919.42446044)
P/E ratio: 170.37592842907893
P/B ratio: 1.6377631731183069
Debt to equity: 0.08470000000000001
Current ratio: 9.42
Interest coverage ratio: -1.0104423209536006
Return on net tangible assets (%): 1.7573322485449183
Buffett classification: The Gruesome
Analyst consensus upside (%): 111.65909090909089
Rule of 40 score: -46.95882370295401
Altman Z-score: 6.131106339539283 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.14048952332701334
Total shareholder yield (%): 0.14048952332701334 (Low Return)
Momentum (%): 1m -3.2401613127520568, 3m 16.121778239059, 6m -0.0886524822695002, 12m -1.5366430260047184, composite 5.931229712357069 (Flat)
Lynch category: Slow Grower (confidence: Low)
Screener: long score 4, short score 7, recommendation: Neutral
Revenue growth 1y (%): 84.56082201477125
Net income growth 1y (%): -48.641455063901006
Revenue deceleration: no
Revenue growth consistency score: 1.4887575496680687
Accrual ratio: 0.044455074516069996
FCF conversion rate: -21.70181408574962
Beneish M-score: -2.218659168112028 (Likely Safe)
ROE (%): 0.23984773211291832
Net margin (%): 1.766050693811095
Asset turnover: 0.110881122571827
Equity multiplier (leverage): 1.2248272402170541
ROE archetype: Low Return
Treasury beta 1y: -0.003624655604890868 (R-squared: 0.000924682762587408)
Insider 90-day net shares: 762353 (net value USD: 273682.00)
ROIC (%): -3.1612448902954284 (pretax: -4.001575810500542)
Incremental ROIC 3y (%): -1.7113147312816597 (pretax: -2.166221178837544)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 57.99999999999999, P/B 36, ROIC 57.99999999999999, revenue growth 1y 0, 6m momentum 12
Sector percentiles: P/E 33.98997134670487, 6m momentum 28.868194842406876
Industry median P/E: 0.15154711900058024; industry median ROIC: 5.985153957145241
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -1941213.8686131386
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PCU.V (Basic Materials — Gold, Canada)
Report date: 2026-01-31 (quarterly)
Stock price: 1.0212765957446808
Market cap: 301663968 (USD: 223454791.1111111)
P/B ratio: 3.5433652251623635
Debt to equity: 0
Current ratio: 0.41
Return on net tangible assets (%): -3.0015551897184625
Buffett classification: The Gruesome
Analyst consensus upside (%): 136.62087912087912
Rule of 40 score: 0
Altman Z-score: 26.746260158718403 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -16.17267248800887, 3m -22.269503546099294, 6m -26.97607760996583, 12m , composite -24.622790578032564 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.0074367431035280976
FCF conversion rate: 0.7334801318416792
Beneish M-score: -2.5364416931197855 (Likely Safe)
ROE (%): -2.9571425670322316
Asset turnover: 0
Equity multiplier (leverage): 1.0597881843153696
ROE archetype: Low Return
Treasury beta 1y: -0.01738960022831436 (R-squared: 0.013442226293969142)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 36.26062322946176, ROIC , revenue growth 1y , 6m momentum 38.10198300283286
Sector percentiles: P/E , 6m momentum 51.94336479733481
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1019
Base cash flow: -2789947.482014389
DCF price per share: base 0, conservative 0, aggressive 0